RBR-2vmk27进行中（未招募）未知
Stability Evaluation and Clinical-Laboratory Study to Verify and Compare Efficay and Safety of Retinoic Acid Cream 0.05% and 5% in Superficial Peels
niversidade Federal de São Paulo0 个研究点开始时间: 2016年1月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 60Y 至 99Y（—）
入选标准
- •Healthy women that past menopause and were not hormone replacement of any kind, over the age of 60; phototypes II and III according to Fitzpatrick's classification (1988) (Appendix 2); presence of superficial actinic keratoses and multiple through proposed score on the scale of Guimarães (2015) (Appendix 3); agreement to avoid sun exposure throughout the study; agreement with the conditions of study, ability to understand and strictly follow the guidelines received, willingness to attend the regular review and signature of IC (Appendix 1).
排除标准
- •Local treatment, except sunscreens, with tretinoin for at least 6 months, other retinoids, alpha-hydroxy acids, polyhydroxy acids, beta-hydroxy acids and ascorbic acid for at least 3 months; previous treatment with oral retinoid in the last 6 months; previous treatment with superficial chemical peels, microdermabrasion and laser non-ablative, for a period not exceeding three months; presence of infectious or inflammatory dermatoses in the upper limbs; chemotherapy in the last three months; clinical evidence of immunosuppression.
研究者
相似试验
尚未招募
Unknown
A clinical study to evaluate safety, in-use tolerability and efficacy of a toothpaste in adult subjects.CTRI/2024/07/071276Patanjali Ayurved Ltd.
尚未招募
Unknown
To evaluate safety, in-use tolerability and efficacy of a toothpaste in healthy subjects.CTRI/2024/07/071277Patanjali Ayurved Ltd.
已完成
2 期
Clinical study to investigate safety, tolerability, efficacy,pharmacokinetics and pharmacodynamics of inhaled multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with moderate to severe COPD– A randomised, double-blind, parallel group, multicenter, phase IIa pilot study –J44.9Chronic obstructive pulmonary disease, unspecifiedDRKS00006087Philipps-Universität Marburg19
进行中（未招募）
不适用
Clinical study to investigate safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with mild allergic asthmaEUCTR2012-003570-77-DEsterna biologicals GmbH & Co. KG
进行中（未招募）
不适用
Clinical study for the assessment of safety and efficacy of Bezafibrate as a drug therapy for patients suffering from an inborn muscular dysfunction characterized by intramuscular lack of energy supplymitochondrial disorderEUCTR2012-002692-34-ATniv.-Klinik für Kinder- und Jugendheilkunde16